You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PR positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in São Paulo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • Radiotherapy
  • +2 more
  • São Paulo, SP, Brazil
    ICESP
Aug 5, 2022

Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Recruiting
  • Breast Cancer
  • Brain Metastases
  • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
  • Guangzhou, Guangdong, China
  • +1 more
Apr 24, 2022

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Ovarian Cancer Trial in Brazil (Palbociclib 125mg, Letrozole 2.5mg)

Active, not recruiting
  • Ovarian Cancer
  • Palbociclib 125mg
  • Letrozole 2.5mg
  • Belo Horizonte, Minas Gerais, Brazil
  • +4 more
Feb 10, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Use of Zoledronic Acid in Breast Cancer Trial in Asyut (Zoledronic Acid 4 MG)

Recruiting
  • Use of Zoledronic Acid in Breast Cancer
  • Zoledronic Acid 4 MG
  • Asyūţ, Asyut, Egypt
    Clinical Oncology Department, Assuit University Hospital
Dec 5, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Metastatic Breast Cancer Trial in Athens

Recruiting
  • Metastatic Breast Cancer
    • Athens, Greece
      Hellenic Society of Medical Oncology
    Feb 9, 2021

    Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

    Not yet recruiting
    • Stage IV (Metastatic) Breast Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 25, 2021

    HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • TQB2440 injection + Trastuzumab + Docetaxel
    • Perjeta + Trastuzumab + Docetaxel
    • Chongqing, Chongqing, China
    • +5 more
    Aug 3, 2023

    Community-acquired Pneumonia, Acute Respiratory Distress Syndrome Trial in Brazil (Positive end-expiratory pressure titration

    Recruiting
    • Community-acquired Pneumonia
    • Acute Respiratory Distress Syndrome
    • Positive end-expiratory pressure titration with driving pressure control
    • ARDSNet ventilatory strategy
    • Londrina, PR, Brazil
    • +5 more
    May 2, 2022

    After Neoadjuvant Chemotherapy for Breast Cancer

    Recruiting
    • TN ER-/PR-/HER2- Breast Cancer
    • +3 more
    • Standard Trimodality Breast Imaging
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    Aug 13, 2021

    Breast Cancer Trial in Cambridge (Megestrol Acetate 40 MG, Megestrol Acetate 160 MG, Letrozole)

    Unknown status
    • Breast Cancer
    • Megestrol Acetate 40 MG
    • +2 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jan 12, 2021

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications Trial in Los Angeles (mucoadhesive

    Completed
    • Estrogen Receptor-positive Breast Cancer
    • +7 more
    • mucoadhesive oral wound rinse
    • laboratory biomarker analysis
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Sep 17, 2020

    Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • +2 more
    • WT1:126-134
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 15, 2021

    Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

    Completed
    Has Results
    • Breast Cancer
    • San Francisco, California
    • +7 more
    Jul 8, 2022

    Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

    Not yet recruiting
    • Gastrooesophageal Cancer
    • Trastuzumab deruxtecan
    • Southampton, Hampshire, United Kingdom
    • +16 more
    Jul 27, 2023

    Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

    Recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +8 more
    • Polatuzumab Vedotin
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 26, 2023

    Granulosa Cell Ovarian Cancer, Low Grade Serous Ovarian/ Primary Peritoneal Cancer, Endometrioid Endometrial Cancer Trial in

    Recruiting
    • Granulosa Cell Ovarian Cancer
    • +2 more
    • Onapristone ER
    • Onapristone ER + Anastrozole
    • Basking Ridge, New Jersey
    • +7 more
    Aug 17, 2022

    Metastatic Beast Cancer Trial in New York (Exemestane, Cyclophosphamide)

    Completed
    Has Results
    • Metastatic Beast Cancer
    • New York, New York
      NYU Cancer Center
    Mar 3, 2020

    Autoimmune Membranous Nephropathy Trial in Manchester, Preston, Salford (Immunoadsorption)

    Completed
    • Autoimmune Membranous Nephropathy
    • Immunoadsorption
    • Manchester, Greater Manchester, United Kingdom
    • +2 more
    Jun 7, 2021

    Breast Tumor, Hormone Receptor Positive Breast Carcinoma Trial in Orange (Abemaciclib, Fulvestrant)

    Recruiting
    • Breast Neoplasm
    • Hormone Receptor Positive Breast Carcinoma
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 15, 2021

    Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Lorlatinib)

    Recruiting
    • Carcinoma
    • Non-Small-Cell Lung
    • Orange, California
    • +31 more
    Dec 6, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Suspended
    • Anatomic Stage I Breast Cancer AJCC v8
    • +23 more
    • Short-Term Fasting
    • Chemotherapy
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 23, 2023

    HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

    Recruiting
    • HER2-positive Breast Cancer
    • +3 more
    • Pertuzumab and tratuzumab fixed dose combination
    • Trastuzumab emtansine
    • Auchenflower, Australia
    • +84 more
    Jan 16, 2023